References
- ROSS R: The pathogenesis of atherosclerosis: a perspec-tive for the 1990's. Nature (1993) 362:801–809.
- EGASHIRA K et al.: Reduction in serum cholesterol withpravastatin improves endothelium-dependent coro-nary vasomotion in patients with hypercholesterolae-mia. Circulation (1994) 89:2519–2524.
- KOGA T et al.: Tissue selectivity of pravastatin sodium,lovastatin and simvastatin. The relationship between inhibition of de novo synthesis and active drug concen-trations in the liver, spleen and testis in rat. Eur. J. Biochem. (1992) 209:315–319.
- LEUNG WH et al.: Beneficial effect of cholesterol-lower-ing therapy on coronary endothelium-dependent re-laxation in hypercholesterolenaic patients. Lancet (1993) 341:1496–1500.
- LIJUAN M et al: Enhancement of migration activity in cholesterol-poor endothelial cells by pre-treating with HMG-CoA reductase inhibitors. Biochem. Biopbys. Res. Comm. (1994) 203:1355–1361.